GlassScriptPhysician profile
Cheryl T Chu
NPI 1871701649
$475.93
in general payments reported to CMS, 2019-2025
12 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.46 · 2020: $72.85 · 2021: $56.18 · 2022: $84.37 · 2023: $24.04 · 2024: $73.35 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $86.97 | 2020-2022 | |
| Novo Nordisk INC | $76.54 | 2021-2025 | Ozempic |
| Exact Sciences Corporation | $70.02 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $65.82 | 2020-2024 | Bexsero |
| Agios Pharmaceuticals, INC. | $36.45 | 2025 | Pyrukynd |
| Merck Sharp & Dohme LLC | $27.18 | 2025 | Capvaxive, Rotateq, Vaqta |
| Alkermes, INC. | $23.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.21 | 2025 | |
| Dexcom, INC. | $19.30 | 2022 | |
| Sanofi Pasteur INC. | $17.46 | 2019 | |
| Cranial Technologies, INC | $17.17 | 2021 | |
| Seqirus USA INC | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.